Dora Ferrari
Corporate Officer/Principal chez CURIS, INC.
Profil
Dora Ferrari is currently the Vice President-Clinical Operations at Curis, Inc. Prior to this, she worked as the Director-Clinical Development & Program Management at ArQule, Inc., a Clinical Research Associate at EPIX Pharmaceuticals, Inc., and the VP-Clinical Development & Program Management at Aileron Therapeutics, Inc. She completed her undergraduate degree at the University of Massachusetts.
Postes actifs de Dora Ferrari
| Sociétés | Poste | Début |
|---|---|---|
| CURIS, INC. | Corporate Officer/Principal | 03/01/2021 |
Anciens postes connus de Dora Ferrari
| Sociétés | Poste | Fin |
|---|---|---|
| ARQULE, INC. | Corporate Officer/Principal | - |
EPIX Pharmaceuticals, Inc.
 EPIX Pharmaceuticals, Inc. Medical SpecialtiesHealth Technology EPIX Pharmaceuticals, Inc. used to develop targeted contrast agents both to improve the capability and expand the use of magnetic resonance imaging (MRI) as a tool for diagnosing human disease. The company was founded in 1988 and was headquartered in Lexington, MA. | Corporate Officer/Principal | - |
| AILERON THERAPEUTICS, INC. | Directeur Technique/Scientifique/R&D | - |
Formation de Dora Ferrari
| University of Massachusetts | Undergraduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 2 |
|---|---|
| AILERON THERAPEUTICS, INC. | Health Technology |
| CURIS, INC. | Health Technology |
| Entreprise privées | 2 |
|---|---|
ArQule, Inc.
 ArQule, Inc. Pharmaceuticals: MajorHealth Technology ArQule, Inc. is a biopharmaceutical company, which engages in the research and development of therapeutics to treat cancers and rare diseases. The company was founded in 1993 and is headquartered in Burlington, MA. | Health Technology |
EPIX Pharmaceuticals, Inc.
EPIX Pharmaceuticals, Inc. Medical SpecialtiesHealth Technology EPIX Pharmaceuticals, Inc. used to develop targeted contrast agents both to improve the capability and expand the use of magnetic resonance imaging (MRI) as a tool for diagnosing human disease. The company was founded in 1988 and was headquartered in Lexington, MA. | Health Technology |
